One study by Wang et al. has shown that treatment with a barbiturate derivative in a CCL4-induced liver fibrosis model system blocked both TGF-β1 and LPS-induced NF-κB signaling pathways and inhibited HSC activation and macrophages recruitment and activation [41]. Here, NFKB1 is linked to Hepatic fibrosis.